Recent findings suggested that hypoxia, as well as some epigenetic modulators, transcription factors and non-coding RNAs are main contributors to ALKBH5 dysregulation in cancer (Table 2; Fig. 4). This evidence concerns the gene ALKBH5 and cancer.